Department: Senior Leadership

Steve Harr, MD, is President and Chief Executive Officer of Sana Biotechnology. Prior to co-founding Sana, Steve served as Chief Financial Officer and Head of Corporate Development for Juno Therapeutics until its acquisition by Celgene in early 2018. He was a member of the Board of Directors of Loxo Oncology prior to its acquisition by […]

John Gerecitano, MD, PhD, is the Senior Vice President of Oncology Research and Development at Sana Biotechnology. Prior to Sana, John served as the Global Medical Head of the Lymphoma Disease Area Stronghold at Johnson & Johnson Innovative Medicine. From 2006 to 2018, John was a practicing oncologist at Memorial Sloan-Kettering Cancer Center (MSKCC) and […]

Aaron Grossman is the Executive Vice President, Chief Legal Officer at Sana Biotechnology. Prior to Sana, from 2011 to 2025, Aaron served as Chief Legal Officer for ZOLL Medical Corporation, a global medical device company based in Chelmsford, MA, where he led the company’s Legal & Compliance Department, with responsibility for all aspects of law, […]

Gary Meininger, MD, is Executive Vice President and Chief Medical Officer at Sana Biotechnology. Prior to joining Sana, Gary served as Senior Vice President and Head of Clinical Development at Vertex Cell and Genetic Therapies (VCGT), where he oversaw all aspects of clinical development for VCGT disease areas, including sickle cell disease, beta-thalassemia, type 1 […]

Dhavalkumar Patel, MD, PhD, is Executive Vice President and Chief Scientific Officer of Sana Biotechnology. Prior to joining Sana in 2024, Dhaval served as Executive Vice President and Chief Scientific Officer of UCB, a multinational biopharmaceutical company headquartered in Brussels, Belgium, where he and his teams contributed to the registration of bimekizumab (Bimzelx®), rozanolixizumab (Rystiggo®) […]

Snehal Patel is Executive Vice President and Chief Technical Officer at Sana Biotechnology. Snehal has a breadth of knowledge and experience in leading roles in Technical Operations, Technology, and Quality Assurance in Biologics, Small Molecules, and most recently in Cell Therapy. Prior to Sana, Snehal was the Global Head and Vice President for Cell Therapy […]